Q2 2022 Abcellera Biologics Inc Earnings Call Transcript
Good afternoon, and welcome to AbCellera's Second Quarter 2022 Business Update and Conference Call. My name is Lydia, and I'll facilitate the audio portion of today's interactive broadcast. (Operator Instructions)
At this time, I'd like to turn the call over to Tryn Stimart, AbCellera's Chief Legal and Compliance Officer.
Thank you. Good afternoon, and welcome to AbCellera's Second Quarter 2022 Business Update. We're pleased to have you with us today where we will discuss the results announced in our press release issued after the market closed today, which you can find on our Investor Relations website.
With me on the call are Dr. Carl Hansen, AbCellera's Chief Executive Officer and President; and Andrew Booth, AbCellera's Chief Financial Officer. The webcast portion of this call contains a slide presentation that we will refer to during the call. If you are following along on the phone and wish to access the slide portion of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
